J Frontier Co., Ltd. (2934) AI Stock Analysis

• Market Cap: ¥9.39B
• Dividend Yield: N/A
• Average Volume (3M): 40.98K
• Price to Earnings (P/E): 98.1
• Beta (1Y): 1.17
• Revenue Growth: 21.39%
• EPS Growth: N/A
• Country: JP
• Employees: 315
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -6.99
• Shares Outstanding: 5,326,465
• 10 Day Avg. Volume: 22,550
• 30 Day Avg. Volume: 40,976
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥1,693.00
• Price Target Upside: -3.92% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 45 Neutral
• Price Target: ¥1,693.00 ▼(-3.92% Downside)

The overall stock score is primarily influenced by financial performance challenges, including inconsistent revenue growth and high leverage risks. Technical analysis suggests short-term bearish momentum, while the high P/E ratio indicates potential overvaluation. The absence of earnings call data and corporate events further limits positive factors.

J Frontier Co., Ltd. Business Overview & Revenue Model

Company Description

J Frontier Co.,Ltd. engages in the healthcare sale, medical care sale, and healthcare marketing businesses in Japan. It is involved in various activities, including online medical care, medication guidance, as well as operates drug delivery platform, medical institutions, and operates dispensing pharmacy. The company engages in distribution of pharmaceuticals products as well as involved in marketing, logistics, and call center activities. J Frontier Co.,Ltd. was incorporated in 2008 and is based in Tokyo, Japan.

How the Company Makes Money

J Frontier Co., Ltd. generates revenue through multiple streams, primarily from software licensing, subscription services, and project-based consulting fees. The company licenses its proprietary software solutions to businesses, offering both one-time purchase options and ongoing subscription models that provide recurring income. Additionally, J Frontier engages in consulting projects, where it collaborates with clients to implement digital transformation strategies, charging fees based on project scope and duration. Strategic partnerships with technology providers and industry leaders further enhance its market reach, allowing the company to offer integrated solutions that attract new clients and drive revenue growth.

J Frontier Co., Ltd. Financial Statement Overview

Summary

J Frontier Co., Ltd. faces challenges in maintaining consistent revenue growth and profitability, with high leverage posing potential risks. While there are signs of improvement in cash flow, the company needs to focus on stabilizing its financial performance and managing debt levels to enhance long-term sustainability.

Income Statement

The income statement shows a mixed performance. Gross profit margin has been relatively stable, but the net profit margin has fluctuated significantly, with recent improvements. Revenue growth has been inconsistent, with a notable decline in the latest period. EBIT and EBITDA margins have also been volatile, indicating challenges in maintaining operational efficiency.

Balance Sheet

The balance sheet indicates a high debt-to-equity ratio, suggesting potential leverage risks. However, the equity ratio has been relatively stable. Return on equity has been negative in recent periods, reflecting profitability challenges. The company needs to manage its debt levels to improve financial stability.

Cash Flow

Cash flow analysis shows improvement in free cash flow growth, but operating cash flow has been inconsistent. The operating cash flow to net income ratio has been negative, indicating cash flow challenges. However, the free cash flow to net income ratio suggests some ability to generate cash relative to net income.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	21.69B	21.50B	17.71B	16.84B	11.88B	8.49B
Gross Profit	9.55B	9.57B	8.33B	7.12B	5.40B	6.63B
EBITDA	-281.87M	914.54M	-1.22B	-1.54B	760.66M	706.10M
Net Income	-1.55B	87.57M	-2.09B	-1.90B	400.52M	424.93M
Balance Sheet
Total Assets	9.05B	9.17B	10.71B	7.24B	6.10B	2.59B
Cash, Cash Equivalents and Short-Term Investments	1.75B	2.17B	1.81B	1.65B	2.96B	1.64B
Total Debt	4.63B	4.34B	5.17B	2.14B	546.79M	75.21M
Total Liabilities	7.02B	7.16B	9.09B	4.53B	1.94B	1.33B
Stockholders Equity	1.26B	1.41B	1.15B	2.48B	4.14B	1.27B
Cash Flow
Free Cash Flow	0.00	447.19M	-1.54B	-1.94B	-377.40M	823.99M
Operating Cash Flow	0.00	509.01M	-1.44B	-1.83B	-366.94M	830.91M
Investing Cash Flow	0.00	470.79M	-1.79B	-1.13B	-860.09M	-7.99M
Financing Cash Flow	0.00	-623.13M	3.39B	1.45B	2.56B	-93.65M

J Frontier Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 1762.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2934, the sentiment is Neutral. The current price of 1762 is below the 20-day moving average (MA) of 1857.55, above the 50-day MA of 1754.64, and above the 200-day MA of 1751.10, indicating a neutral trend. The MACD of 2.73 indicates Positive momentum. The RSI at 43.55 is Neutral, neither overbought nor oversold. The STOCH value of 12.33 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:2934.

J Frontier Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3649	79 Outperform	¥22.82B	19.91	―	1.80%	-6.29%	-22.25%
4320	73 Outperform	¥13.12B	12.47	2.02%	2.31%	7.79%	38592.95%
3939	72 Outperform	¥23.14B	22.75	23.99%	1.33%	13.39%	12.00%
4483	66 Neutral	¥288.96B	46.57	9.63%	0.36%	29.09%	87.01%
2934	45 Neutral	¥9.39B	98.10	―	―	21.39%	―
3902	43 Neutral	¥23.55B	-32.19	―	1.08%	-0.58%	-260.22%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%